Fleet Bioprocessing attending MEDICA 2026
Fleet Bioprocessing will be attending MEDICA 2026 in Düsseldorf this November, with Moya Mellors at the exhibition from 16–18 November.
For Fleet, MEDICA is a valuable opportunity to keep up with developments in point of care diagnostics, precision diagnostics, biomarkers and immunoassay technologies, as well as to discover new ideas from start ups and emerging technology companies.
Moya is particularly interested in new products and approaches that could influence future assay development, lateral flow, ELISA and bioconjugation projects.
These areas connect closely with Fleet’s work in Immunoassay Development, Lateral Flow Assay Development and Bioconjugation, where we provide contract development support to diagnostic and life science companies.
As Fleet’s Lateral Flow Development Manager, Moya brings more than 15 years’ experience in lateral flow assay development, including technical development, project delivery and taking assays from feasibility through to manufacture across a range of applications.
Beyond discovering what is new, MEDICA is also about the people behind the technology. Moya is looking forward to catching up with familiar faces and long-standing contacts across the industry, as well as building new relationships with companies and individuals working across diagnostics, biotechnology and MedTech.
If you will also be in Düsseldorf and would like to catch up, discuss a potential project or simply compare notes on what you have seen at the show, please get in touch via Moya’s LinkedIn or our Contact Us page below.
And if that catch up happens over a currywurst while giving weary feet a rest, even better!
